Abstract:The transcription process is controlled by regulatory elements that are often located in non-coding regions. Among regulatory elements, activities of enhancers that are bound by cell-type specific transcription factors (TFs) are tightly linked to cell identity. Enhancers loop to interact with the promoters of target genes at a distance to drive different cell fates. Evidently, transcriptional dysregulation linked to enhancers that are differentially activated in cancer is an underlying factor in tumorigenesis. To identify enhancers linked to prostate tumorigenesis, we analyzed hundreds of in-house and public H3K27ac ChIP-seq data generated from normal prostate and prostate cancer cell lines and tissues. We identified thousands of prostate cancer-specific enhancers (PSEs) that were activated exclusively in cancer conditions. To further identify the target genes of PSEs, we performed 3C-derived assays, such as Hi-C and Micro-C, and mapped genome-wide interactions. However, they were limited by the resolution to detect enhancer-promoter interactions. The recent development of Region Capture Micro-C (RCMC), a hybridization-based capture Micro-C method, allowed us to deeply map the highly nested interactions between regulatory elements. By utilizing RCMC, we generated high-resolution, focal contact maps that revealed comprehensive enhancer-promoter interactions near PSEs in prostate cancer cells. Interestingly, we found that PSEs loop to other PSEs clustered in the proximal genomic region, in addition to promoters of significantly upregulated genes in cancer compared to normal cells. We termed these regions as multi-connected "3D enhancer-promoter hubs". To mechanistically dissect these hubs, we deleted 5+ PSEs one by one using the CRISPR/Cas9 system and performed multi-omics analyses, including RNA-seq and ChIP-seq. We found that single deletions of a subset of PSEs led to the downregulation of multiple genes looped to the deleted PSE as well as to other PSEs. Moreover, we found that deletion reduced the activity of other connected PSEs. When we further evaluated the chromatin contacts of regulatory elements in the PSE-deleted cells, we observed that many chromatin contacts remained unaffected. Finally, we identified TFs that bind to PSEs, and we are currently in the process of investigating enhancer-promoter hub connectivity by performing knockdown experiments on these TFs. Furthermore, we are using molecular assays to identify PSEs that could exert a phenotypic shift in cancer cell identity to drive prostate tumorigenesis. Overall, our study not only provides mechanistic insights into the spatial regulation of 3D enhancer-promoter hubs but also identifies new non-coding drivers in prostate tumorigenesis. Citation Format: Huan Cao, Zexun Wu, Leonardo Gonzalez-Smith, Seolyn Yang, Suhn K. Rhie. Dissecting the 3D enhancer-promoter hubs in prostate tumorigenesis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1686.

Systematic discovery and functional dissection of enhancers needed for cancer cell fitness and proliferation

Single-cell Multi-Scale Footprinting Reveals the Modular Organization of DNA Regulatory Elements

Genetic and Epigenetic Dysregulation of Transcriptional Enhancers in Cancer

Enhancer Dysfunction in 3D Genome and Disease

Emerging insights into enhancer biology and function

Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitions

Abstract 1689: CRISPR functional genetic screening for immune enhancers of inhibitor receptors in human primary CD8 T cells

Abstract P5-14-02: Identifying oncogenic enhancer elements in TNBC of the Basal-like subtype using single-cell ATAC-seq and RNA-seq

Tissue-specific enhancer functional networks for associating distal regulatory regions to disease

Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells

Abstract 1686: Dissecting the 3D enhancer-promoter hubs in prostate tumorigenesis

Predictive Prioritization of Enhancers Associated with Pancreas Disease Risk

Nested epistasis enhancer networks for robust genome regulation

Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing

An atlas of active enhancers across human cell types and tissues

CenhANCER: a comprehensive cancer enhancer database for primary tissues and cell lines

Regulatory Elements Can Be Essential for Maintaining Broad Chromatin Organization and Cell Viability

BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis

Enhancer selectivity across cell types delineates three functionally distinct enhancer-promoter regulation patterns

An Epigenomic fingerprint of human cancers by landscape interrogation of super enhancers at the constituent level

Demystifying the secret mission of enhancers: linking distal regulatory elements to target genes